REFERENCES
- Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann. Intern. Med 2002; 136(1)42–53
- Vogler B.K., Pittler M.H., Ernst E. The efficacy of ginseng. A systematic review of randomized clinical trials. Eur. J. Clin. Pharmacol 1999; 55(8)567–575
- Kim J.Y., Germolec D.R., Luster M.I. Panax ginseng as a potential immunomodulator; studies in mice. Immunopharmacol. Immunotoxicol 1990; 12(2)257–276
- Yun Y.S., Lee Y.S., Jo S.K., Jung I.S. Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Planta Med 1993; 59(6)521–524
- Lee Y.S., Chung I.S., Lee I.R., Kim K.H., Hong W.S., Yun Y.S. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 1997; 17(1A)323–331
- Kim K.H., Lee Y.S., Jung I.S., Park S.Y., Chung H.Y., Lee I.R., Yun Y.S. Acidic polysaccharide from panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 1998; 64(2)110–115
- Jie Y.H., Cammisuli S., Baggiolini M. Immunodulatory effects of panax ginseng C.A. Meyer in the mouse. Agent Action 1984; 15(3/4)386–391
- Scaglione F., Cattaneo G., Alessandria M., Cogo R. Efficacy and safety of the standardized ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drug Exp. Clin. Res 1996; 22(2)65–72
- Song Z.J., Johansen H.K., Faber V., Høiby N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 1997; 105(6)438–444
- Kim Y.W., Song D.K., Kim W.H., Lee K.M., Wie M.B., Kim Y.H., Kee S.H., Cho M.K. Long-term oral administration of ginseng extract decreases serum gamma-globulin and IgG1 isotype in mice. J. Ethnopharmacol 1997; 58(1)55–58
- Liou C.J., Li M.L., Tseng J. Intraperitoneal injection of ginseng extract enhances both immunoglobulin and cytokine production in mice. Am. J. Chin. Med 2004; 32(1)1–14
- Snapper C.M., Paul W.E. Interferon-γ and B cell stimulatory factor-1 recipicolly regulate Ig isotype production. Science 1987; 236(4804)944–947
- Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol 1995; 13: 251–276
- Song Z., Johansen H.K., Fabber V., Moser C., Kharazmi A., Rygaard J., HØiby N. Ginseng treatment reduces bacterial load and lung pathology in chronic pseudomonas aeruginosa pneumonia in rats. Antimicrobiol. Agent. Chemother 1997; 41(5)961–964
- Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med 1989; 170(6)2081–2095
- Groux H., O’Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389(6652)737–742
- Moore K.W., de Waal Malefyt R., Coffman R.L., O’Garra A. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol 2001; 19: 683–765
- Taga K., Tosato G. IL-10 inhibits human T cell proliferatiob and IL-2 production. J. Immunol 1992; 148(4)1143–1148
- Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D-H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 1992; 89(5)1890–1893
- Pecanha L.M., Snapper C.M., Lees A., Yamaguchi H., Mond J.J. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J. Immunol 1993; 150(8)3215–3223